Eubacteriales Family XIII. Incertae Sedis Details: NCBI 543314, gram-negative or unknown [family]

| Clostridiales Family XIII. Incertae Sedis

  1. Mucosal Surfaces:

    • Verrucomicrobia bacteria are often found in mucosal surfaces, including the gastrointestinal tract. Their presence in the mucosal environment suggests potential interactions with the host's immune system and other microorganisms in these regions.
  2. Akkermansia muciniphila:

    • One of the well-studied genera within Verrucomicrobia is Akkermansia. Akkermansia muciniphila is a species known to inhabit the mucus layer of the intestinal lining. Research has suggested that A. muciniphila may have positive effects on metabolic health, including its potential role in maintaining mucosal integrity and modulating metabolic pathways.
  3. Mucus Degradation:

    • Some members of Verrucomicrobia, including Akkermansia species, are specialized in utilizing mucin, a component of the protective mucus layer in the gut. This ability to degrade mucin may influence the gut environment and the interactions between the microbiota and the host.
  4. Metabolic Health:

    • Akkermansia muciniphila has been associated with metabolic health benefits in preclinical studies. It has been linked to improvements in glucose metabolism, insulin sensitivity, and lipid metabolism. However, the translation of these findings to human health is an area of ongoing investigation.
  5. Immunomodulation:

    • Verrucomicrobia bacteria may play a role in immunomodulation, influencing the host's immune response. The interactions between Verrucomicrobia and the immune system are complex and context-dependent.
  6. Associations with Disease:

    • Altered abundances of Verrucomicrobia have been observed in studies of the gut microbiota in various health conditions. Changes in the relative abundance of Verrucomicrobia, including increases or decreases, have been reported in conditions such as inflammatory bowel disease (IBD), obesity, and diabetes. However, the specific contributions of Verrucomicrobia to these conditions are still being explored.

A lot more information is available when you are logged in and raise the display level

Other Sources for more information:

More Information
Statistics NCBI Data Punk End Products Produced

Lab Reporting

Different labs use different software to read the sample. See this post for more details.
One lab may say you have none, another may say you have a lot! - This may be solely due to the software they are using to estimate.
We deem lab specific values using values from the KM method for each specific lab to be the most reliable.

Desired Levels Suggestions for Eubacteriales Family XIII. Incertae Sedis

Using Kaltoft-Moldrup Heuristic Using uploaded data for Eubacteriales Family XIII. Incertae Sedis

Lab Low and High are calculated using the formula that most labs use: Mean - 2 Standard Deviation to Mean + 2 Standard Deviation

These are values that are computed from lab specific samples (Patent Pending)
LabKM LowKM Percentile LowKM HighKM Percentile HighLab LowLab HighMean MedianStandard DeviationBox Plot LowBox Plot High
* 1 0 %ile 1358 92 %ile 0 2400 739.9 429 846.9 0 1845
biomesight 10 0 %ile 530 90.9 %ile 0 2914 459.9 160 1252.2 0 600
thorne 63 0 %ile 724 100 %ile 0 510 205.6 158 155.2 58 266
thryve 51 11.5 %ile 1145 90.7 %ile 0 6229 1004.7 283 2665.6 0 1321
ubiome 18 0 %ile 1827 91.4 %ile 0 5683 1320.1 621 2226.1 0 2085
Lab Suggestions for Eubacteriales Family XIII. Incertae Sedis
Eubacteriales Family XIII. Incertae Sedis (NCBI 543314) per million
Low Boundary High Boundary Low Boundary %age High Boundary %age Lab Samples
Statistic by Lab Source for Eubacteriales Family XIII. Incertae Sedis
These desired values are reported from the lab reports
Lab Frequency Seen Average Standard Deviation Sample Count Lab Samples
AmericanGut 66.667 %   0.048 %  0.033 % 10.0 15
BiomeSight 83.609 %   0.046 %  0.121 % 2377.0 2843
BiomeSightRdp 90.625 %   0.059 %  0.083 % 29.0 32
bugspeak 100 %   0.026 %  % 1.0 1
CerbaLab 100 %   0.057 %  0.016 % 3.0 3
CosmosId 56.25 %   0.018 %  0.033 % 18.0 32
custom 13.559 %   0.011 %  0.026 % 8.0 59
es-xenogene 24.138 %   0.037 %  0.021 % 7.0 29
Medivere 100 %   0.024 %  0.015 % 7.0 7
Microba 10.714 %   0.125 %  0.135 % 3.0 28
Microba1 100 %   0.14 %  % 1.0 1
SequentiaBiotech 86.111 %   0.135 %  0.099 % 31.0 36
Thorne 84.706 %   0.014 %  0.013 % 72.0 85
Thryve 94.275 %   0.103 %  0.352 % 1301.0 1380
Tiny 100 %   0.003 %  % 1.0 1
uBiome 82.702 %   0.132 %  0.223 % 655.0 792

Symptoms Associated with Eubacteriales Family XIII. Incertae Sedis From Citizen Science Studies

Click on Impact for information if high or low levels are causing the impact

MagnitudeImpactSymptom

To see medical conditions associated you may be logged in

And display level must be raised above public.

I would like to know what can change the quality that I have

Data Contradictions β€” Limits of Certainity

To get the list of studies, you must be logged in and raise your display level.

πŸ§™? Search Hints:
General Substance Specific Substance Effect
Common Supplements Exercise 1 Studies recorded. The consensus is Decreases👪, Click for details.
Common Supplements sodium butyrate 1 Studies recorded. The consensus is Decreases👪, Click for details.
Common Supplements Tributyrin 1 Studies recorded. The consensus is Decreases👪, Click for details.
Diet Style dietary fiber 2 Studies recorded. The consensus is Increases👶👪, Click for details.
Diet Style high fiber diet 2 Studies recorded. The consensus is Increases👶👪, Click for details.
Diet Style high sugar diet 1 Studies recorded. The consensus is Decreases📓, Click for details.
Diet Style high-fat diets 1 Studies recorded. The consensus is Decreases📓, Click for details.
Diet Style low protein diet 2 Studies recorded. The consensus is Increases👶👪, Click for details.
Food (excluding seasonings) brown rice 2 Studies recorded. The consensus is Increases👶👪, Click for details.
Food (excluding seasonings) whey 1 Studies recorded. The consensus is Decreases👪, Click for details.
Herb or Spice triphala 1 Studies recorded. The consensus is Increases👪, Click for details.
Prebiotics and similar Psyllium (Plantago Ovata Husk) 1 Studies recorded. The consensus is Decreases👪, Click for details.
Prebiotics and similar resistant starch 2 Studies recorded. The consensus is Increases👶👪, Click for details.
Probiotics Pediococcus pentosaceus 1 Studies recorded. The consensus is Decreases👪, Click for details.
Sugar and similar saccharin 1 Studies recorded. The consensus is Increases📓, Click for details.
Vitamins, Minerals and similar iron 1 Studies recorded. The consensus is Increases📓, Click for details.
Vitamins, Minerals and similar vitamin d 1 Studies recorded. The consensus is Increases👪, Click for details.

This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.

Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 Β§β€―1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.

Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.


The awesome web hosting site that we use. Try it if you need to host (or unhappy with current provider)